Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Abcam Expresses Surprise At Dr. Milner's Actions, Believes His Opposition May Be An Attempt To Create Confusion Among Shareholders Before The Vote

Author: Benzinga Newsdesk | September 15, 2023 02:07am

Abcam plc (NASDAQ:ABCM) ("Abcam" or the "Company"), notes today's announcement by Dr. Jonathan Milner. The Company considers it surprising that Dr. Milner has taken active steps to oppose the deal without reviewing the full details in the Scheme Circular to be published in connection with the proposed acquisition of all of the outstanding shares of Abcam by Danaher Corporation ("Danaher") for $24.00 per share in cash (the "Transaction"), which appears to be an attempt to create confusion for shareholders ahead of voting on the Transaction.

Posted In: ABCM DHR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist